These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7778070)

  • 21. Suppression and modulation of cellular and humoral immune responses to Haemophilus influenzae type B (Hib) conjugate vaccine in hib-diphtheria-tetanus toxoids-acellular pertussis combination vaccines: a study in a rat model.
    Mawas F; Newman G; Burns S; Corbel MJ
    J Infect Dis; 2005 Jan; 191(1):58-64. PubMed ID: 15593004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lest we forget acute epiglottitis.
    Selvadurai H; McIntyre P; Mellis C
    J Paediatr Child Health; 1998 Jun; 34(3):306-7. PubMed ID: 9633988
    [No Abstract]   [Full Text] [Related]  

  • 23. [Elimination of Haemophilus influenzae type b meningitis after introduction of vaccination].
    Kolmos HJ
    Ugeskr Laeger; 1993 Feb; 155(5):327-8. PubMed ID: 8447005
    [No Abstract]   [Full Text] [Related]  

  • 24. Natural and vaccine-induced immunity against Haemophilus influenzae type b in patients with beta-thalassemia.
    Spoulou VI; Tsoumas DL; Ladis V; Spentzou A; Theodoridou MC
    Vaccine; 2006 Apr; 24(16):3050-3. PubMed ID: 16519975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemophilus influenzae type b vaccine--booster campaign.
    Heath PT; Ramsay ME
    BMJ; 2003 May; 326(7400):1158-9. PubMed ID: 12775589
    [No Abstract]   [Full Text] [Related]  

  • 26. Haemophilus influenzae type b conjugate vaccine is highly effective in the Ugandan routine immunization program: a case-control study.
    Lee EH; Lewis RF; Makumbi I; Kekitiinwa A; Ediamu TD; Bazibu M; Braka F; Flannery B; Zuber PL; Feikin DR
    Trop Med Int Health; 2008 Apr; 13(4):495-502. PubMed ID: 18312475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Haemophilus influenzae type b vaccines on the epidemiology of bacterial meningitis.
    Wenger JD
    Infect Agents Dis; 1993 Oct; 2(5):324-32. PubMed ID: 8173815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case-control studies of the effectiveness of vaccines: validity and assessment of potential bias.
    Shapiro ED
    Pediatr Infect Dis J; 2004 Feb; 23(2):127-31. PubMed ID: 14872178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity and safety of combined diphtheria tetanus whole cell pertussis hepatitis B/ Haemophilus influenzae type b vaccine in Indian infants.
    Bavdekar SB; Maiya PP; Subba Rao SD; Datta SK; Bock HL
    Indian Pediatr; 2007 Jul; 44(7):505-10. PubMed ID: 17684303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
    Pichichero ME; Bernstein H; Blatter MM; Schuerman L; Cheuvart B; Holmes SJ;
    J Pediatr; 2007 Jul; 151(1):43-9, 49.e1-2. PubMed ID: 17586189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The PRP-D vaccination of Danish children. A study of immunogenicity of a Haemophilus influenzae type b vaccine coadministered with Di-Te-Pol to Danish children].
    Konradsen HB; Ejlertsen T; Henrichsen J
    Ugeskr Laeger; 1993 Sep; 155(37):2872-5. PubMed ID: 8259610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antipolyribosyl ribitol phosphate response of premature infants to primary and booster vaccination with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus/Haemophilus influenzae type b vaccine.
    Omeñaca F; Garcia-Sicilia J; García-Corbeira P; Boceta R; Torres V
    Pediatrics; 2007 Jan; 119(1):e179-85. PubMed ID: 17145903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose.
    Berrington JE; Cant AJ; Matthews JN; O'Keeffe M; Spickett GP; Fenton AC
    Pediatrics; 2006 Apr; 117(4):e717-24. PubMed ID: 16549502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AAFP, AAP and ACIP release new childhood immunization schedule.
    Am Fam Physician; 1996 Jan; 53(1):395-6. PubMed ID: 8546057
    [No Abstract]   [Full Text] [Related]  

  • 35. Continued shortage of Haemophilus influenzae Type b (Hib) conjugate vaccines and potential implications for Hib surveillance--United States, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1252-5. PubMed ID: 19023262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated polio vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
    Partridge S; Alvey J; Bernstein H; Blatter M; Bottenfield G; Guerrero J; Senders SD; Schuerman L; Cheuvart B; Holmes SJ
    Vaccine; 2007 Feb; 25(10):1806-13. PubMed ID: 17240493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity study of Haemophilus influenzae type B conjugate vaccine in Indian infants.
    Phadke MA; Kulkarni MV; Sovani VB; Lokeshwar MR; Venkataraman R
    Indian Pediatr; 1997 Sep; 34(9):779-83. PubMed ID: 9492415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic evaluation of Haemophilus influenzae type b vaccination in Moscow, Russian Federation.
    Platonov AE; Griffiths UK; Voeykova MV; Platonova OV; Shakhanina IL; Chistyakova GG; Robertson SE;
    Vaccine; 2006 Mar; 24(13):2367-76. PubMed ID: 16413949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preventive vaccination (DPT, HiB, polio, MMR) in hepatitis B virus carrier status?].
    Wiersbitzky S
    Kinderarztl Prax; 1993 Dec; 61(10):376-7. PubMed ID: 8145455
    [No Abstract]   [Full Text] [Related]  

  • 40. Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants.
    Zepp F; Knuf M; Heininger U; Jahn K; Collard A; Habermehl P; Schuerman L; Sänger R
    Vaccine; 2004 Jun; 22(17-18):2226-33. PubMed ID: 15149781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.